Immunomic Therapeutics
Immunomic Therapeutics Inc. is a privately held biotechnology company based in Hummelstown, PA, focused on the advancement of nucleic acid immunotherapy platforms. Through its proprietary UNiversal Intracellular Targeted Expression (UNITE) technology, the company aims to develop innovative vaccines that harness the body's natural immune responses to improve treatment outcomes in cancer, allergies, and animal health.
The company's current pipeline includes several investigational therapies, such as ITI-1001 for glioblastoma multiforme, which is undergoing Phase 1 clinical trials. Immunomic Therapeutics is dedicated to enhancing immune-based therapies to extend patients' lives and overall health through its pioneering research and development efforts.
Generated from the website
Also at this address
You might also like
Partial Data by Foursquare.